Biovas Medical
PrivateLast Round
Series C
Aug 4, 2021
Est. Valuation
$800M
Total Funding Raised
$100M
Company Overview
Biovas Medical is a medical device company that specializes in the research, development, production, and sales of minimally invasive circulatory intervention devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biovas Medical Comparables
Compare Biovas Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrosMed Medical | 88% | |
| Kossel Medtech (Suzhou) Co., Ltd. | 87% | |
| APT Medical Inc. | 83% |
Biovas Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 4, 2021 | ||||
| Series B | Nov 23, 2020 | ||||
| Series A Extension | Aug 29, 2019 | ||||
| Series A | Apr 21, 2018 |
Biovas Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boyu Capital | Series C |
| Hillhouse Investment | Series B, Series C |
| Goldman Sachs Asset Management Private Equity | Series C |
| CAS Star | Series A |
| Starquest Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 4, 2021
$100M round with participation from Boyu Capital and Goldman Sachs.
- Nov 23, 2020
Led by Hillhouse Investment
Biovas Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biovas Medical's valuation, stock price, and market status.
Is Biovas Medical a public or private company?
Biovas Medical is a private company.
What is the current stock price of Biovas Medical?
Biovas Medical is a private company, so its shares have no public market price. Caplight tracks Biovas Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biovas Medical worth (valuation)?
Biovas Medical's valuation is estimated at $800.0M based on funding round data.
Can I buy Biovas Medical stock?
Biovas Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biovas Medical's last funding round?
Biovas Medical's most recent funding round was Series C on August 4, 2021.
Who are the main investors in Biovas Medical?
Key investors in Biovas Medical include Hillhouse Investment.
Will Biovas Medical IPO soon?
No public IPO plans have been announced for Biovas Medical.
How can I track Biovas Medical secondary market activity?
Caplight tracks bids, offers, and trades in Biovas Medical's shares on secondary markets.